-31.0%
MRNA vs DBX
+35.3%
-66.3%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | DBX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.3% | -2.5% | -2.3% |
| 7D | -12.7% | +1.1% | -13.8% | -13.2% |
| 30D | -20.7% | -7.3% | -13.3% | -18.7% |
| 3M | +46.3% | -0.3% | +46.5% | +44.0% |
| 6M | +305.2% | +23.0% | +282.2% | +257.7% |
| YTD | +561.2% | +22.0% | +539.3% | +478.9% |
| 1Y | +772.1% | +17.5% | +754.6% | +675.4% |
| 3Y | +147.0% | +22.4% | +124.5% | +96.0% |
| All | -31.0% | +35.3% | -66.3% | -52.3% |
Cumulative growth
Daily Returns
Daily percentage return beside DBX.
Daily Out/Under-Performance
Portfolio return minus DBX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DBX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded DBX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling